Not every assay needs the same substrate. But every assay needs the right one.

In recent years, the country has promulgated centralized bulk-buying policy for high value medical consumables in the field of medical devices.

As an important medical resource to save lives, blood safety is very important and blood screening is the most critical link to ensure blood safety.

A pair of new studies examines genetic variations that confer risk of developing autism spectrum disorder, providing insight into the different phenotypes associated with the disorder.

San Diego-based diagnostics firm CorDx said on Thursday that it has obtained CE-IVD marks for a PCR test and a lateral flow test for monkeypox.

On August 17, AutoBio Diagnostics released its first-half results of 2022. The company achieved CNY 2.070 billion revenue by the end of June, with a year-on-year increase of 23.41%. The net profit attributable to shareholders was CNY 534 million, increasing 29.28% than the last year.

French diagnostics firm Eurobio Scientific said on Wednesday that it has agreed to acquire Genome Diagnostics, also known as GenDx, for €135 million ($137.2 million) in cash.

Agilent Technologies announced after the close of the market Tuesday that its fiscal third quarter revenues grew 8 percent year over year, topping the consensus Wall Street estimate.

Recently, four products of Tianlong Science and Technology, including E. coli, Salmonella, Staphylococcus aureus, and Listeria monocytogenes DNA detection kits, have obtained EU CE certification.

Illumina and the Minderoo Foundation said on Tuesday that they have signed a partnership to commit A$40 million ($27.8 million) towards sequencing DNA in marine systems.

Ginkgo Bioworks reported after the close of the market on Monday that its second quarter 2022 revenues grew 231 percent year over year, driven by biosecurity service revenues.

August 11, the Second Roche Pan-Tumor Precision Diagnosis and Innovation Ecology Forum was officially opened at Roche Pharma China Shanghai Campus, where participants discussed solutions for pan-tumor precision diagnosis and treatment.